Search results
Results from the WOW.Com Content Network
Franklin and his attorney, Thomas M. Greene, filed a lawsuit, Franklin v. Parke-Davis, under the False Claims Act in federal district court in Boston. In the first off-label promotion case ever litigated in a whistleblower suit under the False Claims Act, the settlement was announced after eight years of litigation in May 2004.
Legal claims against the pharmaceutical industry have varied widely over the past two decades, including Medicare and Medicaid fraud, off-label promotion, and inadequate manufacturing practices. [ 3 ] [ 4 ] With respect to off-label promotion, specifically, a federal court recognized off-label promotion as a violation of the False Claims Act ...
taxpayer standing in a Dormant Commerce Clause case Sereboff v. Mid Atlantic Medical Services, Inc. 547 U.S. 356 (2006) fiduciary's recovery of personal injury settlement under ERISA: eBay Inc. v. MercExchange, L.L.C. 547 U.S. 388 (2006) nature of patent injunctions - revisiting Continental Paper Bag Co. v. Eastern Paper Bag Co.
Each year, the Court receives approximately 2,000 new case filings. In most cases, the litigants seek review of Michigan Court of Appeals decisions, but the Supreme Court also hears cases of attorney misconduct (through a bifurcated disciplinary system comprising an investigation and prosecution agency – the Attorney Grievance Commission – and a separate adjudicative agency – the ...
The Michigan Attorney General's Office filed motions Thursday to not prosecute Sutherland on the charges of embezzlement of $100,000 or more and embezzlement of a vulnerable adult $100,000 or more ...
Oliver is one of a handful of attorneys who specialize in representing whistleblowers who bring lawsuits under a Civil War-era law that encourages people to report fraud against the government. These so-called qui tam cases are filed under seal, with the hope that the Justice Department will investigate and then join in.
Within 48 hours of being put on Paxil Schell killed his wife, daughter, infant granddaughter, and himself. Tim Tobin, Schell's son-in-law, took legal action against SmithKline (now GlaxoSmithKline). The Tobin case was heard in Wyoming from May 21 to June 6, 2001. The jury returned a guilty verdict against SmithKline and awarded Tobin $6.4 million.
Multiple state Medicaid programs have placed limits on how much an addict can take per dose. Such restrictions are based on the mistaken premise that addiction can be cured in a set time frame. In the report, the researchers wrote that the state restrictions seemingly go against established medical practice.